Moshe has been working alongside BioInnovate contemporary, Eoin Bambury, since the 2013/14 fellowship program. Together, they co-founded Signum Surgical, a start-up whose key focus is developing novel minimally invasive technologies to treat colorectal diseases. The company has raised over €3 million to date with initial seed funding from the Enterprise Ireland Commercialisation Fund followed by Series A funding from a myriad of investment parties including Chip Hance (former CEO of Creganna), Medtech Syndicate Nominee, Switzerland based Glanzmann Enterprises, Rising Tide Europe 1, the Western Development Commission and Enterprise Ireland. Eoin and Moshe continue to build their IP portfolio and aim to commercialise their platform device in 2019.